EUVIMEDOtkrijte EUVIMED
Crossref

Conversion to tacrolimus alone compared to full immunosuppression following cardiac transplantation (TACTFUL)

Aaron P Pearston iD, Amanda I Ingemi iD, Zachary A Shaeffer, Chad M Cameron, Katharine T Biagi iD, Myra Gobble, Amin Yehya iD, David A Baran iD

Clinical Transplantation · 2023

DOI: 10.1111/ctr.15140 ↗

At a glance

Journal article in Clinical Transplantation, 2023. Written by Aaron P Pearston and 7 co-authors. Institution: Sentara Norfolk General Hospital, Norfolk, Virginia, USA. Major MEDLINE topics: Tacrolimus, Heart Transplantation. Cited 1 times so far (Crossref); 11 references.

SažetakSubjectsBibliografski podaciCiteRelated studies

Abstract (original language)

Background

Cardiac transplantation requires lifelong immunosuppressant medications to prevent rejection. However, some patients may not tolerate multiple immunosuppressants due to adverse effects. At our institution, patients may be converted to monotherapy with tacrolimus if unable to tolerate a combination regimen. This study evaluated the outcomes among patients converted to tacrolimus monotherapy compared with those maintained on combination immunosuppression.

Methods

This single‐center, retrospective cohort study included patients who received heart transplants at Sentara Norfolk General Hospital between January 2015 and July 2021. Patients were classified as receiving tacrolimus monotherapy (Mono) or combination immunosuppression (Combo). The primary outcome was all‐cause mortality with key secondary outcomes including incidence of 2R/3R rejection, necessity for renal replacement therapy, and infection.

Results

112 patients were included (Mono = 25, Combo = 87). Median age at transplant was 53.8 years (Mono) and 52.1 years (Combo). The most common reasons for conversion to monotherapy were leukopenia, infection, and gastrointestinal (GI) distress. There was no difference in mortality (0 in Mono, 11 in Combo; p = .09) or percentage of patients with 2R/3R rejection (24% in Mono, 32.2% in Combo; p = .43). No Mono group patients experienced rejection after converting from combination therapy. 24% of Mono group patients resumed at least one additional immunosuppressive medication during the study period. Median time to monotherapy was 9.0 months, with a total median duration on monotherapy of 16.0 months. A median of 3.3 years of follow‐up was observed for patients in Mono and 3.4 years in Combo ( p = .29).

Conclusion

Selected patients who do not tolerate combination immunosuppression can be safely transitioned to tacrolimus monotherapy as a means of controlling adverse events without an increased risk of mortality or rejection.

Subjects

MeSH terms (MEDLINE)

TacrolimusHeart TransplantationHumansRetrospective StudiesImmunosuppressive AgentsImmunosuppression TherapyGraft Rejection

Author keywords

heart transplantimmunosuppressionminimizedmonotherapy

Substances

TacrolimusImmunosuppressive Agents

Authors and institutions

  • Sentara Norfolk General Hospital, Norfolk, Virginia, USA.
  • Cleveland Clinic Heart, Vascular and Thoracic Institute, Weston, Florida, USA.

ORCID profiles: Aaron P Pearston, Amanda I Ingemi, Katharine T Biagi, Amin Yehya, David A Baran

Cite

APA

Pearston, A. P., Ingemi, A. I., Shaeffer, Z. A., Cameron, C. M., Biagi, K. T., Gobble, M., Yehya, A., & Baran, D. A. (2023). Conversion to tacrolimus alone compared to full immunosuppression following cardiac transplantation (TACTFUL). Clinical Transplantation. https://doi.org/10.1111/ctr.15140

Vancouver

Pearston AP, Ingemi AI, Shaeffer ZA, Cameron CM, Biagi KT, Gobble M, et al. Conversion to tacrolimus alone compared to full immunosuppression following cardiac transplantation (TACTFUL). Clinical Transplantation. 2023. doi:10.1111/ctr.15140

BibTeX
@article{Pearston2023,
  author = {Pearston, Aaron P and Ingemi, Amanda I and Shaeffer, Zachary A and Cameron, Chad M and Biagi, Katharine T and Gobble, Myra and Yehya, Amin and Baran, David A},
  title = {Conversion to tacrolimus alone compared to full immunosuppression following cardiac transplantation (TACTFUL)},
  journal = {Clinical Transplantation},
  year = {2023},
  doi = {10.1111/ctr.15140}
}
Start for free →